Benjamin Frush MD, a resident in internal medicine-pediatrics at Vanderbilt University Medical Center in Nashville, argues in favor of a role that physicians can play in integrating religion into their clinical practice. Rob Poole MB, FRCPsych, contends that physicians should never incorporate a religious element into clinical practice.
Patients and their families are advocating for their right to access the latest medical research papers to help find potential treatments and understand health conditions.
Finding the balance of empathy and professionalism is a skill that not enough of us recognize as essential, and even fewer seek to teach.
Attempting to engage on an intellectual level about the heady concept of brain death while in the throes of bereavement can often lead to mistrust and confusion.
For adolescents, contact sports increase the risk of brain health complications.
Despite disappointing results, tenecteplase’s story in stroke treatment might not be over.
A survey showed 67.3% of patient advocacy organizations received industry funding, while 11.9% received more than half of their funding from industry.
Ronald Petersen, MD, PhD, discusses the implications of Eli Lilly’s failed solanezumab trial on the future of Alzheimer’s disease research.
Katherine A. Roberts, MD, FACE, ECNU, discusses her choice to opt out of Medicare and offers advice to physicians considering doing the same.
Recent research found benefits in outcome outweighed any increase in hemorrhagic complications in patients with large infarcts.
Although the study did not demonstrate efficacy of glyburide, differences were seen in the amount midline shift at 3-4 days.
Key opinion leaders weigh in given recent findings that increased use of therapeutic coma in status epilepticus may not be linked with improved outcomes.
The greatest hurdle in developing effective treatments for TBI lies in the varied and dynamic pathophysiology and incomplete understanding of factors leading to poor outcome.
HIPAA doesn’t require providers to encrypt devices or electronic information, but one could say it is strongly encouraged.
Despite 3 large randomized trials and updated guidelines, the question of PFO closure remains a complex entity.
Huma Sheikh, MD, discusses some of her top picks from presentations made at the 2016 AHS annual meeting.
A joint medical and surgical approach may ensure the best outcome.
The idea of low-dose tPA will likely not be abandoned despite recent findings.
Ticagrelor may have an opportunity to shine in patients already on aspirin or clopidogrel.
Changing the stigma around and frequency of injury in football requires a collaborative, educational effort involving all stakeholders.
Dr Albert Favate addresses some of the hottest topics concerning stroke care and patient management.
Dr Conidi discusses some of the major points addressed in the blockbuster film that could impact clinical practice.
Ruben Kuzniecky, MD, outlines what to expect at this year’s American Epilepsy Society Annual Meeting.
Interventional stroke treatment continues to rapidly evolve as health care providers implement new protocols to ensure more rapid, successful treatment.
Technology called Brain Network Activation allows health care professionals to evaluate brain network function after traumatic brain injury and during recovery.
New recommendations for the treatment of acute stroke put emergency physicians and neurology stroke specialists at odds.
The ongoing INTREPID clinical trial is evaluating the safety and effectiveness of the Vercise™ DBS System.
Steven Croft, MD, lays down his reasons why ICD-10 will do more bad than good for physician and patient communities.
The meeting was abuzz with excitement about a new potential treatment targeted directly at migraines.
Huma U. Sheikh, MD, shares her thoughts on sessions of interest from the upcoming AHS Annual Scientific Meeting.
The RiverSpring at Night program accommodates the altered sleep cycles of Alzheimer’s dementia patients with a drug-free approach to nighttime activities and comprehensive care.
Michael Ronemus, PhD, was forced to step out from behind the microscope when his own son was diagnosed with autism.
Lynn Webster, MD, calls out media reports on a new study that claims opioid use during pregnancy may be harmful to infants.
A multidisciplinary team of providers come together to address epilepsy cases of patients with limited access to care.
All too often, physicians, coaches, and athletes are swayed into making a quick conclusion about concussion risk after a hard hit.
Results of a twin study showed that insomnia was moderately heritable, but in childhood, it was thought to be a result of behavior.
Kamil Ugurbil, PhD, is leading the monumental 5-year Human Connectome brain imaging project that’s making use of 7T MRI technology.
Changes made to autism spectrum disorders in DSM-5 have implications for how Asperger’s is diagnosed and treated.
The long-awaited results of the MR CLEAN trial are sure to affect the future of acute stroke treatment.
Prejudice against pharma-funded research could have an ill effect on the health-care industry.